Toward a Plasmon-Based Biosensor throughout a Thermoresponsive Hydrogel.

ACS Appl Polym Mater

IMEM-BRT's Group, Departament d'Enginyeria Química, EEBE, Universitat Politècnica de Catalunya, C/Eduard Maristany, 10-14, Ed. I, second floor, 08019, Barcelona, Spain.

Published: November 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This study investigates the potential of thermoresponsive hydrogels as innovative substrates for future in vitro diagnostic (IVD) applications using AVAC technology, developed and patented by the Mecwins biomedical company. In order to convert the hydrogel in a substrate compatible with AVAC technology, the following prerequisites were established: (1) the hydrogel layer needs to be permeable to gold nanoparticles (AuNPs), and (2) the optical properties of the hydrogel should not interfere with the detection of AuNPs with AVAC technology. These two key aspects are evaluated in this work. A silicon substrate (Sil) was coated with a layer of a thermosensitive hydrogel (TSH) based on poly(-isopropylacrylamide--,'-methylene bis(acrylamide) (PNIPAAm--MBA). The TSH offers the advantage of easy modulation of its porosity through cross-linker adjustments, crucial for the plasmonic nanoparticle (NP) permeation. The platforms, denominated as (Sil)--(PNIPAAm--MBA), were fabricated by changing the cross-linker concentrations and exploring three deposition methods: drop casting (DC), spin coating (SC), and 3D printing (3D); the DC approach resulted in a very homogeneous and thin hydrogel layer, very suitable for the final application. Furthermore, after physical-chemical characterization, the TSH demonstrated its functionality in regulating nanoparticle absorption, and AVAC technology's capability to precisely identify such NPs through the hydrogel matrix was validated. The proposed hydrogel platform fulfills the initial requirements, opening the possibility for employing these hydrogels as dynamic substrates in sandwich immunoassay devices. The next step in the development of the hydrogel substrate would be its functionalization with biorecognition groups to allow for biomarker detection. By leveraging their enhanced capture efficiency and the ability to manipulate particle flow thermally, we anticipate a significant advancement in diagnostic methodologies, combining the spatial benefits of three-dimensional hydrogel structures with the precision of AVAC's digital detection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11590450PMC
http://dx.doi.org/10.1021/acsapm.4c02255DOI Listing

Publication Analysis

Top Keywords

avac technology
12
hydrogel
10
hydrogel substrate
8
hydrogel layer
8
plasmon-based biosensor
4
biosensor thermoresponsive
4
thermoresponsive hydrogel
4
hydrogel study
4
study investigates
4
investigates potential
4

Similar Publications

African swine fever (ASF) is one of the most devastating diseases affecting the global pig industry. Therefore, the development of safe and effective vaccines is crucial in combating the virus. The AVAC ASF LIVE vaccine, produced from an attenuated genotype II ASF virus (ASFV) strain with the deletion of six MGF genes and cultured in a Diep's macrophage (DMAC) cell line, has been officially licensed for use and commercialization in Vietnam.

View Article and Find Full Text PDF

Accurate detection and quantification of biomarkers at ultra-low levels is critical for disease diagnosis and effective treatment. Traditional detection technologies often lack the sensitivity, specificity, throughput, or multiplexing capacity required for comprehensive diagnostics, providing only a subset of these requirements. Here, we introduce AVAC, an automated optical technology for rapid and accurate biomarker detection with ultra-high sensitivity that significantly outperforms standard clinical assays.

View Article and Find Full Text PDF

Toward a Plasmon-Based Biosensor throughout a Thermoresponsive Hydrogel.

ACS Appl Polym Mater

November 2024

IMEM-BRT's Group, Departament d'Enginyeria Química, EEBE, Universitat Politècnica de Catalunya, C/Eduard Maristany, 10-14, Ed. I, second floor, 08019, Barcelona, Spain.

This study investigates the potential of thermoresponsive hydrogels as innovative substrates for future in vitro diagnostic (IVD) applications using AVAC technology, developed and patented by the Mecwins biomedical company. In order to convert the hydrogel in a substrate compatible with AVAC technology, the following prerequisites were established: (1) the hydrogel layer needs to be permeable to gold nanoparticles (AuNPs), and (2) the optical properties of the hydrogel should not interfere with the detection of AuNPs with AVAC technology. These two key aspects are evaluated in this work.

View Article and Find Full Text PDF

Innovative Peptide-Based Plasmonic Optical Biosensor for the Determination of Cholesterol.

Biosensors (Basel)

November 2024

Biochemistry and Molecular Biology Unit, Department of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, Campus "Aurelio Saliceti" Via Renato Balzarini n. 1, 64100 Teramo, Italy.

Article Synopsis
  • Plasmonic biosensors are gaining popularity in scientific and medical fields due to their ability to detect biomolecular and chemical interactions with high sensitivity and precision.
  • One of the ongoing challenges is accurately detecting low molecular weight substances, like free cholesterol, which is crucial for diagnostic tools but difficult due to its size and properties.
  • The study introduces a new approach using a cholesterol-binding peptide along with plasmonic optical readout that achieves a very low detection limit and operates effectively in a specific concentration range, potentially enhancing cholesterol measurement methods.
View Article and Find Full Text PDF

Introduction: The Dual Prevention Pill (DPP) combines oral pre-exposure prophylaxis (PrEP) with oral contraception (OC) to prevent HIV and pregnancy. Noting the significant role played by the private sector in delivering family planning (FP) services in countries with high HIV burden, high level of private sector OC uptake, and the recent growth in self-care and technology-based private sector channels, we undertook qualitative research in Kenya, South Africa and Zimbabwe to prioritize private sector service delivery approaches for the introduction of the DPP.

Methods: Between March 2022 and February 2023, we conducted a literature review and key informant interviews with 34 donors and implementing partners, 19 government representatives, 17 private sector organizations, 13 pharmacy and drug shop representatives, and 12 telehealth agencies to assess the feasibility of DPP introduction in private sector channels.

View Article and Find Full Text PDF